For decades, doctors and researchers have been working diligently to discover new treatments and provide more options for patients with Duchenne muscular dystrophy (DMD), a debilitating genetic disease that ravages the muscles in the body and leads to a loss of movement and coordination.

Children’s Hospital of Philadelphia hosted The Runway, presented by the Jacovini Family, a contemporary lunchtime fashion show at the Mann Center curated by top Philadelphia-area boutiques and designers with proceeds benefitting CHOP’s Neuroscience Center. This year, more than $845,000 was raised!

The Movement Disorders Program is one of the only programs of its kind in the country and provides life-changing results.

Patients with this complex neurological disorder experience a wide variety of symptoms, which can be managed with early and proper diagnosis.

STXBP1-related disorders include gastrointestional and respiratory symptoms in certain patients, according to extensive interviews with caregivers.

A $25 million gift from an anonymous donor to Penn Medicine and Children’s Hospital of Philadelphia (CHOP) will establish the Center for Epilepsy and Neurodevelopmental Disorders (ENDD), accelerating collaborative research in genetic therapies for neurodevelopmental disorders.

The Neuroscience Center prioritizes partnered care relationships that maximize expertise, access to novel therapies, and local care.

Founded in 2005, the Pediatric Multiple Sclerosis and Neuroinflammatory Disorders Clinic at CHOP is recognized as a Partner in MS Care – Center for Comprehensive Care by the National Multiple Sclerosis Society.

Through collaboration with research partners, patients, foundations, and community members, we are working to defeat childhood brain cancer and find better treatments for current patients. Read about recent milestones we’ve hit to accelerate pediatric brain tumor research.

Two researchers from Children’s Hospital of Philadelphia (CHOP) were recently selected by the health and science news outlet STAT as 2022 Wunderkinds, an award that celebrates the next generation of scientific superstars who are making significant contributions to biomedical research.